FULGENT GENETICS, INC. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate
FULGENT GENETICS, INC. (FLGT) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate of 0.00% for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate · last filed 2016-11-14
- 2016-09-30: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 9 month 0.00%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 9 month |
|---|---|
| 2016-09-30 | 0.00% 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |